Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 6, 2006, Pages 952-956

  Jeon, Yunseok ^a   Ryu, Jung Hee ^a   Lim, Young Jin ^a   Kim, Chong Sung ^a   Bahk, Jae Hyon ^a   Yoon, Seung Zhoo ^a   Choi, Ju Youn ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Milrinone; Norepinephrine; Off pump coronary artery bypass surgery; Vasopressin

Indexed keywords

MILRINONE; NORADRENALIN; VASOPRESSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOTENSION; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE;

AGED; CORONARY ARTERY BYPASS, OFF-PUMP; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOTENSION; INTRAOPERATIVE CARE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MILRINONE; NOREPINEPHRINE; PHOSPHODIESTERASE INHIBITORS; PROSPECTIVE STUDIES; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VASOPRESSINS;

EID: 33646548233     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.02.032     Document Type: Article

References (24)

1. Mager G., Klocke R., Kux A., Hopp H.W., and Hilger H.H. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. Am Heart J 121 (1991) 1974-1983
2. Seino Y., Momomura S., Takano T., Hayakawa H., and Katoh K. Multicenter, double-blind study of intravenous for patients with acute heart failure in Japan. Crit Care Med 24 (1996) 1490-1497
3. Jaski B., Fifer M., Wright R., Braunwald E., and Colucci W.S. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest 75 (1985) 643-649
4. Vlahakes G.K. Management of pulmonary hypertension and right ventricular failure: another step forward. Ann Thorac Surg 61 (1996) 1051-1052
5. Gold J.A., Cullinane S., Chen J., Oz M.C., Oliver J.A., and Landry D.W. Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 28 (2000) 249-252
6. Talbot M.P., Tremblay I., Denault A.Y., and Belisle S. Vasopressin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg 120 (2000) 401-402
7. Landry D.W., Levin H.R., Gallant E.M., Seo S., D'Alessandro D., Oz M.C., and Oliver J.A. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25 (1997) 1279-1282
8. Abboud F.M., Floras J.S., Aylward P.E., Guo G.B., Gupta B.N., and Schmid P.G. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27 (1990) 106-115
9. Okamura T., Ayajiki K., Fujioka H., and Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens 17 (1999) 673-678
10. Suzuki Y., Satoh S., Oyama H., Takayasu M., and Shibuya M. Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke 24 (1993) 1049-1053
11. Evora P.R., Pearson P.J., and Schaff H.V. Aarginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery: V1-receptor-mediated production of nitric oxide. Chest 103 (1993) 1241-1245
12. Russ R.D., and Walker B.R. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am J Physiol 262 (1992) H743-H747
13. Wallace A.W., Tunin C.M., and Shoukas A.A. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol 257 (1989) H1228-H1234
14. Dunser M.W., Mayr A.J., Ulmer H., Ritsch N., Knotzer H., Pajk W., Luckner G., Mutz N.J., and Hasibeder W.R. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93 (2001) 7-13
15. Morelli A., Rocco M., Conti G., Orecchioni A., De Gaetano A., Cortese G., and Coluzzi F. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30 (2004) 597-604
16. Vlahakes G.J., Turley K., and Hoffman J.I. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63 (1981) 87-95
17. Belenkie I., Horne S.G., Dani R., Smith E.R., and Tyberg J.V. Effects of aortic constriction during experimental acute right ventricular pressure loading: further insights into diastolic and systolic ventricular interaction. Circulation 92 (1995) 546-554
18. Feneck R.O. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European milrinone multicentre trial group. J Cardiothorac Vasc Anesth 6 (1992) 554-562
19. Kim J.H., Ham B.M., Kim Y.L., Bahk J.H., Ryu H.G., Jeon Y.S., and Kim K.B. Prophylactic milrinone during OPCAB of posterior vessels: implication in angina patients taking beta-blockers. Eur J Cardiothorac Surg 24 (2003) 770-776
20. Lobato E.B., Urdaneta F., Martin T.D., and Gravenstein N. Effects of milrinone versus epinephrine on grafted internal mammary flow after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14 (2000) 9-11
21. Sulek C.A., Blas M.L., and Lobato E.B. Milrinone increases middle cerebral artery blood flow velocity after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 16 (2002) 64-69
22. Suzuki Y., Satoh S., Oyama H., Takayasu M., Shibuya M., and Sugita K. Vasopressin mediated vasodilation of cerebral arteries. J Auton Nerv Syst 49 (1994) S129-S132
23. Vanhoutte P.M., Katusic Z.S., and Shepherd J.T. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertens Suppl 2 (1984) S421-S422
24. Rudichenko V.M., and Beierwaltes W.H. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res 32 (1995) 100-105